Comorbidity and its relevance on general hospital based mortality in major depressive disorder: A naturalistic 12-year follow-up in general hospital admissions

Journal of Psychiatric Research

Volumn 52, Issue 1, 2014, Pages 28-35

  Schoepf, Dieter ^a   Uppal, Hardeep ^b   Potluri, Rahul ^c   Chandran, Suresh ^d   Heun, Reinhard ^a,e  

^a UNIVERSITY OF BONN   (Germany)

^b Brooklands Hospital   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

^d Department of Acute Medicine ^*  (United Kingdom)

^e ROYAL DERBY HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Major depressive disorder; Mortality; Physical comorbidity; Public health; Risk factors

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENERAL HOSPITAL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; AGED; ASTHMA; CASE CONTROL STUDY; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; LONGITUDINAL STUDY; PSYCHOLOGICAL RATING SCALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALS, GENERAL; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84895884174     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.01.010     Document Type: Article

References (39)

1. Ali S., Stone M.A., Peters J.L., Davies M.J., Khunti K. The prevalence of co-morbid depression in adults with type-2 diabetes: a systematic review and meta-analysis. Diabet Med 2006, 23(11):1165-1173.
2. Atlantis E., Fahey P., Cochrane B., Smith S. Bidirectional associations between clinically relevant depression or anxiety and chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. Chest 2013, 10.1378/chest.12-1911.
3. Beary M., Hodgson R., Wildgust H.J. Acritical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. JPsychopharmacol 2012, 26(5):52-61.
4. Black S.A., Markides K.S., Ray L.A. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type-2 diabetes. Diabetes Care 2003, 26:2822-2828.
5. Boschloo L., Vogelzangs N., van den Brink W., Smit J.H., Veltman D.J., Beekman A.T.F., et al. Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry 2012, 200(6):476-484.
6. Brown E.S., Suppes T., Khan D.A., Carmody T.J. Mood changes during prednisone bursts in outpatients with asthma. JClin Psychopharmacol 2002, 22:55-61.
7. Coleman S.M., Katon W., Lin E., Von Korff M. Depression and death in diabetes; 10-year follow-up of all-cause and cause-specific mortality in a diabetic cohort. Psychosomatics 2013, 10.1016/j. psym.2013.02.015.
8. Egede L.E. Major depression in individuals with chronic medical disorders. Prevalence, correlates and association with health resource utilization. Lost productivity and functional disability. Gen Hosp Psychiatry 2007, 29(5):409-416.
9. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R.R., et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58:175-189.
10. Gallo J.J., Morales K., Bogner H., Raue P.J., Zee J., Bruce M.L., et al. Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trail in primary care. Br Med J 2013, 346:f2570. 10.1136/bmj.f2570.
11. George L.M., Maddock K. Accuracy of in-hospital activity notifications for infectious diseases. Br Med J 1979, 1:1332-1339.
12. Glassman A.H., Jackson W.K., Walsh B.T., et al. Cigarette craving, smoking withdrawal, and clonidine. Science 1984, 226(4676):864-866.
13. Glassman A.H., Stetner F., Walsh B.T., Raizman P.S., Fleiss J.L., Cooper T.B., et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAm Med Assoc 1988, 259(19):2863-2866.
14. Glassman A.H., Helzer J.E., Covey L.S., Cottler L.B., Stetner F., Tipp J.E., et al. Smoking, smoking cessation, and major depression. JAm Med Assoc 1990, 264(12):1546-1549.
15. Grant B.F., Stinson F.S., Hasin D.S., Dawson D.A., Chou S.P., Anderson K. Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on alcohol and related conditions. Arch Gen Psychiatry 2004, 61:1226-1233.
16. Hanania N.A., Mullerova H., Locantore N.W., Vestbo J., Watkins M.L., Wouters E.F.M., et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011, 183:604-611.
17. Hasin D.S., Grant B.F. Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry 2002, 59:794-800.
18. Heun R., Schoepf D., Potluri R., Natalwala A. Alzheimer's disease and co-morbidity: increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up. Eur Psychiatry 2013, 28(1):40-48.
19. Hirschfeld R.M.A. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry 2001, 3:244-254.
20. Holt R.I.G., Phillips D.I.W., Jameson K.A., Cooper C., Dennison E.M., Peveler R.C. The relationship between depression, anxiety and cardiovascular disease: findings from the Hertfordshire Cohort Study. JAffect Disord 2013, 10.1016/j.jad.2013.02.026.
21. John U., Meyer C., Rumpf H.J., Hapke U. Depressive disorders are related to nicotine dependence in the population but do not necessarily hampers smoking cessation. JClin Psychiatry 2004, 65(2):169-176.
22. Kessler R.C., Bromer E.J. The epidemiology of depression across cultures. Annu Rev Public Health 2013, 34:119-138.
23. Lavoie K.L., Bacon S.L., Barone S., Cartier A., Ditto B., Labrecque M. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?. Chest 2006, 130:1039-1047.
24. Lin E.H., Rutter C.M., Katon W., Heckbert S.R., Ciechanowski P., Liver M.M., et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010, 33:264-269.
25. McCauley E., Katon W., Russo J., Richardson L., Lozano P. Impact of anxiety and depression on functional impairment in adolescents with asthma. Gen Hosp Psychiatry 2007, 29(3):214-222.
26. Meyer C.M., Armenian H.K., Eaton W.W., Ford D.E. Incident hypertension associated with depression in the Baltimore Epidemiologic Catchment area follow-up study. JAffect Disord 2004, 83(2-3):127-133.
27. Nirantharakumar K., Marshall T., Kennedy A., Narendan P., Hemming K., Coleman J.J. Hypoglycemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized. Diabet Med 2012, 29(12):445-448.
28. Nunes S., Vargas H.O., Prado E., Barbosa D.S., de Melo L.P., Dodd S., et al. The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. Neurosci Biobehav Rev 2013, 37(8):1336-1345.
29. Park M., Katon W.J., Wolf F.M. Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry 2013, 35:217-225.
30. Phung T.K., Andersen B.B., Høgh P., Kessing L.V., Mortensen P.B., Waldemar G. Validity of dementia diagnoses in the Danish in-hospital registers. Dement Geriat Cogn Disord 2007, 24(3):220-228.
31. Rush A.J., Warden D., Wisniewski S.R., Fava M., Trivedi M.H., Gaynes B.N., et al. STAR*D: revising conventional wisdom. CNS Drugs 2009, 23:627-647.
32. Sato S., Yeh T.L. Challenges in treating patients with major depressive disorder: the impact of biological and social factors. CNS Drugs 2013, 27(1):5-10.
33. Schoepf D., Heun R., Weiffenbach O., Herrmann S., Maier W. The 4-week prevalence of somatoform disorders and associated psychosocial impairment. Nervenarzt 2003, 74(3):245-251.
34. Schoepf D., Potluri R., Uppal H., Natalwala A., Narendan P., Heun R. Type-2 diabetes mellitus in schizophrenia: increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow up. Eur Psychiatry 2012, 27(1):33-42.
35. Schoepf D., Uppal H., Potluri R., Heun R. Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci 13 Aug 2013, [Epub ahead of print]. 10.1007/s00406-013-0436-x.
36. Van Dooren F.E.P., Nefs G., Schram M.T., Verhey F.R., Denollet J., Pouwer F. Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS ONE 2013, 8(3):e57058. 10.1371/journal.pone.0057058.
37. Watkins L.L., Koch G.G., Sherwood A., Blumenthal J.A., Davidson J.R., O'Connor C., et al. Association of anxiety and depression with all cause mortality in individuals with coronary heart disease. JAm Heart Assoc 2013, 2:e000068. 10.1161/JAHA.112.000068.
38. World Health Organisation The global burden of disease: 2004 update; Part 1, Part 2, Part 3, Part 4 2004.
39. Young A.S., Klap R., Sherbourne C.D., Wells K.B. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58:55-61.